{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:17:13Z","timestamp":1793297833977,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Ferroptosis, a regulated form of cell death characterized by iron-dependent phospholipid peroxidation, remains poorly understood in the context of esophageal cancer development and its regulatory mechanisms. Through comprehensive bioinformatic analyses, we identified ferroptosis-related pathways as crucial mediators in esophageal cancer progression, with ZIP8 emerging as a key regulatory element. We observed significant upregulation of ZIP8 in esophageal cancer specimens, which correlated with poor clinical outcomes. Functional studies demonstrated that ZIP8 depletion significantly attenuated cellular proliferation in vitro. Mechanistically, elevated ZIP8 expression enhanced zinc-dependent phosphorylation of CREB, leading to upregulation of the ferroptosis suppressor GPX4 and inhibition of this iron-dependent cell death modality. Significantly, we discovered that the natural compound Nobiletin targeted ZIP8, inhibiting Esophageal squamous cell carcinoma (ESCC) cell growth in vitro and in vivo. Our findings demonstrate ZIP8 as a potential therapeutic target in ESCC and suggest that promoting ferroptosis through ZIP8 inhibition may represent a novel anti-cancer strategy for ESCC therapy.<\/jats:p>","DOI":"10.1038\/s41419-025-07692-z","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T18:26:45Z","timestamp":1746556005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["ZIP8 modulates ferroptosis to drive esophageal carcinoma progression"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhaojie","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoping","family":"Yanzhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6710-4647","authenticated-orcid":false,"given":"Guoguo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"key":"7692_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"7692_CR2","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1136\/gutjnl-2020-321600","volume":"69","author":"M Arnold","year":"2020","unstructured":"Arnold M, Ferlay J, van Berge Henegouwen MI, Soerjomataram I. Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut. 2020;69:1564\u201371.","journal-title":"Gut"},{"key":"7692_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","volume":"25","author":"LA Torre","year":"2016","unstructured":"Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends\u2013an update. Cancer Epidemiol Biomark Prev. 2016;25:16\u201327.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"7692_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-nutr-033009-083312","volume":"29","author":"LA Lichten","year":"2009","unstructured":"Lichten LA, Cousins RJ. Mammalian zinc transporters: nutritional and physiologic regulation. Annu Rev Nutr. 2009;29:153\u201376.","journal-title":"Annu Rev Nutr"},{"key":"7692_CR5","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1158\/1078-0432.CCR-09-2405","volume":"16","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Bharadwaj U, Logsdon CD, Chen C, Yao Q, Li M. ZIP4 regulates pancreatic cancer cell growth by activating IL-6\/STAT3 pathway through zinc finger transcription factor CREB. Clin Cancer Res. 2010;16:1423\u201330.","journal-title":"Clin Cancer Res"},{"key":"7692_CR6","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1111\/cas.13737","volume":"109","author":"H Jin","year":"2018","unstructured":"Jin H, Liu P, Wu Y, Meng X, Wu M, Han J, et al. Exosomal zinc transporter ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer. Cancer Sci. 2018;109:2946\u201356.","journal-title":"Cancer Sci"},{"key":"7692_CR7","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1053\/j.gastro.2019.10.038","volume":"158","author":"M Liu","year":"2020","unstructured":"Liu M, Zhang Y, Yang J, Cui X, Zhou Z, Zhan H, et al. ZIP4 Increases expression of transcription factor ZEB1 to promote integrin \u03b13\u03b21 signaling and inhibit expression of the gemcitabine transporter ENT1 in pancreatic cancer cells. Gastroenterology. 2020;158:679\u201392.e1.","journal-title":"Gastroenterology"},{"key":"7692_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1124\/mol.106.024521","volume":"70","author":"L He","year":"2006","unstructured":"He L, Girijashanker K, Dalton TP, Reed J, Li H, Soleimani M, et al. ZIP8, member of the solute-carrier-39 (SLC39) metal-transporter family: characterization of transporter properties. Mol Pharm. 2006;70:171\u201380.","journal-title":"Mol Pharm"},{"key":"7692_CR9","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.bbrc.2007.11.067","volume":"365","author":"Z Liu","year":"2008","unstructured":"Liu Z, Li H, Soleimani M, Girijashanker K, Reed JM, He L, et al. Cd2+ versus Zn2+ uptake by the ZIP8 HCO3\u2013dependent symporter: kinetics, electrogenicity and trafficking. Biochem Biophys Res Commun. 2008;365:814\u201320.","journal-title":"Biochem Biophys Res Commun"},{"key":"7692_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.taap.2009.02.017","volume":"238","author":"L He","year":"2009","unstructured":"He L, Wang B, Hay EB, Nebert DW. Discovery of ZIP transporters that participate in cadmium damage to testis and kidney. Toxicol Appl Pharm. 2009;238:250\u20137.","journal-title":"Toxicol Appl Pharm"},{"key":"7692_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.bbrc.2011.05.134","volume":"410","author":"B Wang","year":"2011","unstructured":"Wang B, He L, Dong H, Dalton TP, Nebert DW. Generation of a Slc39a8 hypomorph mouse: markedly decreased ZIP8 Zn2+\/(HCO3\u2212)2 transporter expression. Biochem Biophys Res Commun. 2011;410:289\u201394.","journal-title":"Biochem Biophys Res Commun"},{"key":"7692_CR12","doi-asserted-by":"publisher","first-page":"34032","DOI":"10.1074\/jbc.M112.367284","volume":"287","author":"CY Wang","year":"2012","unstructured":"Wang CY, Jenkitkasemwong S, Duarte S, Sparkman BK, Shawki A, Mackenzie B, et al. ZIP8 is an iron and zinc transporter whose cell-surface expression is up-regulated by cellular iron loading. J Biol Chem. 2012;287:34032\u201343.","journal-title":"J Biol Chem"},{"key":"7692_CR13","first-page":"477","volume":"18","author":"Z Mei","year":"2018","unstructured":"Mei Z, Yan P, Wang Y, Liu S, He F. Knockdown of zinc transporter ZIP8 expression inhibits neuroblastoma progression and metastasis in vitro. Mol Med Rep. 2018;18:477\u201385.","journal-title":"Mol Med Rep"},{"key":"7692_CR14","doi-asserted-by":"publisher","first-page":"G569","DOI":"10.1152\/ajpgi.00165.2018","volume":"315","author":"L Liu","year":"2018","unstructured":"Liu L, Geng X, Cai Y, Copple B, Yoshinaga M, Shen J, et al. Hepatic ZIP8 deficiency is associated with disrupted selenium homeostasis, liver pathology, and tumor formation. Am J Physiol Gastrointest Liver Physiol. 2018;315:G569\u2013g79.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"7692_CR15","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"7692_CR16","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16:1180\u201391.","journal-title":"Nat Cell Biol"},{"key":"7692_CR17","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575:688\u201392.","journal-title":"Nature"},{"key":"7692_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22:381\u201396.","journal-title":"Nat Rev Cancer"},{"key":"7692_CR19","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.1038\/s41467-021-23902-6","volume":"12","author":"D Chen","year":"2021","unstructured":"Chen D, Chu B, Yang X, Liu Z, Jin Y, Kon N, et al. iPLA2\u03b2-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4. Nat Commun. 2021;12:3644.","journal-title":"Nat Commun"},{"key":"7692_CR20","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1158\/2159-8290.CD-20-1453","volume":"11","author":"SK Tan","year":"2021","unstructured":"Tan SK, Mahmud I, Fontanesi F, Puchowicz M, Neumann CKA, Griswold AJ, et al. Obesity-Dependent adipokine chemerin suppresses fatty acid oxidation to confer ferroptosis resistance. Cancer Discov. 2021;11:2072\u201393.","journal-title":"Cancer Discov"},{"key":"7692_CR21","doi-asserted-by":"publisher","first-page":"103211","DOI":"10.1016\/j.redox.2024.103211","volume":"75","author":"C Berndt","year":"2024","unstructured":"Berndt C, Alborzinia H, Amen VS, Ayton S, Barayeu U, Bartelt A, et al. Ferroptosis in health and disease. Redox Biol. 2024;75:103211.","journal-title":"Redox Biol"},{"key":"7692_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520:57\u201362.","journal-title":"Nature"},{"key":"7692_CR23","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nature24637","volume":"551","author":"SW Alvarez","year":"2017","unstructured":"Alvarez SW, Sviderskiy VO, Terzi EM, Papagiannakopoulos T, Moreira AL, Adams S, et al. NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis. Nature. 2017;551:639\u201343.","journal-title":"Nature"},{"key":"7692_CR24","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.chembiol.2020.03.011","volume":"27","author":"A Anandhan","year":"2020","unstructured":"Anandhan A, Dodson M, Schmidlin CJ, Liu P, Zhang DD. Breakdown of an ironclad defense system: the critical role of NRF2 in mediating ferroptosis. Cell Chem Biol. 2020;27:436\u201347.","journal-title":"Cell Chem Biol"},{"key":"7692_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13020-019-0270-9","volume":"14","author":"H Luo","year":"2019","unstructured":"Luo H, Vong CT, Chen H, Gao Y, Lyu P, Qiu L, et al. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine. Chin Med. 2019;14:48.","journal-title":"Chin Med"},{"key":"7692_CR26","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/cam4.2108","volume":"8","author":"Y Xiang","year":"2019","unstructured":"Xiang Y, Guo Z, Zhu P, Chen J, Huang Y. Traditional Chinese medicine as a cancer treatment: modern perspectives of ancient but advanced science. Cancer Med. 2019;8:1958\u201375.","journal-title":"Cancer Med"},{"key":"7692_CR27","doi-asserted-by":"publisher","first-page":"127539","DOI":"10.1016\/j.foodchem.2020.127539","volume":"336","author":"M Zheng","year":"2021","unstructured":"Zheng M, Lu S, Xing J. Enhanced antioxidant, anti-inflammatory and \u03b1-glucosidase inhibitory activities of citrus hesperidin by acid-catalyzed hydrolysis. Food Chem. 2021;336:127539.","journal-title":"Food Chem"},{"key":"7692_CR28","doi-asserted-by":"crossref","unstructured":"Ashrafizadeh M, Zarrabi A, Saberifar S, Hashemi F, Hushmandi K, Hashemi F, et al. Nobiletin in cancer therapy: how this plant derived-natural compound targets various oncogene and onco-suppressor pathways. Biomedicines. 2020;8:110.","DOI":"10.3390\/biomedicines8050110"},{"key":"7692_CR29","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2741\/4719","volume":"24","author":"N Li","year":"2019","unstructured":"Li N, Zhang Z, Jiang G, Sun H, Yu D. Nobiletin sensitizes colorectal cancer cells to oxaliplatin by PI3K\/Akt\/MTOR pathway. Front Biosci. 2019;24:303\u201312.","journal-title":"Front Biosci"},{"key":"7692_CR30","first-page":"1785","volume":"34","author":"C Chen","year":"2014","unstructured":"Chen C, Ono M, Takeshima M, Nakano S. Antiproliferative and apoptosis-inducing activity of nobiletin against three subtypes of human breast cancer cell lines. Anticancer Res. 2014;34:1785\u201392.","journal-title":"Anticancer Res"},{"key":"7692_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.14715\/cmb\/2020.66.5.33","volume":"66","author":"Z Xu","year":"2020","unstructured":"Xu Z, Wu D, Fu D, Tang C, Ge J, Zhang Z, et al. Nobiletin inhibits viability of human renal carcinoma cells via the JAK2\/STAT3 and PI3K\/Akt pathway. Cell Mol Biol (Noisy-le-Gd). 2020;66:199\u2013203.","journal-title":"Cell Mol Biol (Noisy-le-Gd)"},{"key":"7692_CR32","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1021\/pr0605668","volume":"6","author":"R Shi","year":"2007","unstructured":"Shi R, Kumar C, Zougman A, Zhang Y, Podtelejnikov A, Cox J, et al. Analysis of the mouse liver proteome using advanced mass spectrometry. J Proteome Res. 2007;6:2963\u201372.","journal-title":"J Proteome Res"},{"key":"7692_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/mc.23144","volume":"59","author":"Y Xie","year":"2020","unstructured":"Xie Y, Dong CD, Wu Q, Jiang Y, Yao K, Zhang J, et al. Ornithine decarboxylase inhibition downregulates multiple pathways involved in the formation of precancerous lesions of esophageal squamous cell cancer. Mol Carcinog. 2020;59:215\u201326.","journal-title":"Mol Carcinog"},{"key":"7692_CR34","doi-asserted-by":"publisher","first-page":"102985","DOI":"10.1016\/j.redox.2023.102985","volume":"69","author":"T Zhang","year":"2023","unstructured":"Zhang T, Wang S, Hua D, Shi X, Deng H, Jin S, et al. Identification of ZIP8-induced ferroptosis as a major type of cell death in monocytes under sepsis conditions. Redox Biol. 2023;69:102985.","journal-title":"Redox Biol"},{"key":"7692_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.freeradbiomed.2024.06.004","volume":"222","author":"S Wang","year":"2024","unstructured":"Wang S, Gu J, Bian J, He Y, Xu X, Wang C, et al. Nesfatin-1 mitigates calcific aortic valve disease via suppressing ferroptosis mediated by GSH\/GPX4 and ZIP8\/SOD2 axes. Free Radic Biol Med. 2024;222:149\u201364.","journal-title":"Free Radic Biol Med"},{"key":"7692_CR36","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/emmm.201302507","volume":"5","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Yang J, Cui X, Chen Y, Zhu VF, Hagan JP, et al. A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth. EMBO Mol Med. 2013;5:1322\u201334.","journal-title":"EMBO Mol Med"},{"key":"7692_CR37","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s13046-021-02146-8","volume":"40","author":"H Li","year":"2021","unstructured":"Li H, Shen X, Ma M, Liu W, Yang W, Wang P, et al. ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K\/AKT pathway. J Exp Clin Cancer Res. 2021;40:340.","journal-title":"J Exp Clin Cancer Res"},{"key":"7692_CR38","doi-asserted-by":"crossref","unstructured":"Wang Z, Zhang X, Tian X, Yang Y, Ma L, Wang J, et al. CREB stimulates GPX4 transcription to inhibit ferroptosis in lung adenocarcinoma. Oncol Rep. 2021;45:88.","DOI":"10.3892\/or.2021.8039"},{"key":"7692_CR39","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1017\/S0007114515000148","volume":"113","author":"F Turati","year":"2015","unstructured":"Turati F, Rossi M, Pelucchi C, Levi F, La Vecchia C. Fruit and vegetables and cancer risk: a review of southern European studies. Br J Nutr. 2015;113:S102\u201310.","journal-title":"Br J Nutr"},{"key":"7692_CR40","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/S1470-2045(14)70420-6","volume":"15","author":"H Wilke","year":"2014","unstructured":"Wilke H, Muro K, Van Cutsem E, Oh SC, Bodoky G, Shimada Y, et al. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial. Lancet Oncol. 2014;15:1224\u201335.","journal-title":"Lancet Oncol"},{"key":"7692_CR41","doi-asserted-by":"publisher","first-page":"107686","DOI":"10.1016\/j.pharmthera.2020.107686","volume":"216","author":"L Zhang","year":"2020","unstructured":"Zhang L, Song J, Kong L, Yuan T, Li W, Zhang W, et al. The strategies and techniques of drug discovery from natural products. Pharmacol Ther. 2020;216:107686.","journal-title":"Pharmacol Ther"},{"key":"7692_CR42","doi-asserted-by":"publisher","first-page":"154902","DOI":"10.1016\/j.phymed.2023.154902","volume":"116","author":"M Chen","year":"2023","unstructured":"Chen M, Zhang R, Chen Y, Chen X, Li Y, Shen J, et al. Nobiletin inhibits de novo FA synthesis to alleviate gastric cancer progression by regulating endoplasmic reticulum stress. Phytomedicine. 2023;116:154902.","journal-title":"Phytomedicine"},{"key":"7692_CR43","doi-asserted-by":"publisher","first-page":"154610","DOI":"10.1016\/j.phymed.2022.154610","volume":"110","author":"Y Wu","year":"2023","unstructured":"Wu Y, Li Q, Lv LL, Chen JX, Ying HF, Ruan M, et al. Nobiletin inhibits breast cancer cell migration and invasion by suppressing the IL-6-induced ERK-STAT and JNK-c-JUN pathways. Phytomedicine. 2023;110:154610.","journal-title":"Phytomedicine"},{"key":"7692_CR44","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1021\/acs.jafc.9b07908","volume":"68","author":"R Zhang","year":"2020","unstructured":"Zhang R, Chen J, Mao L, Guo Y, Hao Y, Deng Y, et al. Nobiletin triggers reactive oxygen species-mediated pyroptosis through regulating autophagy in ovarian cancer cells. J Agric Food Chem. 2020;68:1326\u201336.","journal-title":"J Agric Food Chem"},{"key":"7692_CR45","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.aax3769","volume":"366","author":"C Pohl","year":"2019","unstructured":"Pohl C, Dikic I. Cellular quality control by the ubiquitin-proteasome system and autophagy. Science. 2019;366:818\u201322.","journal-title":"Science"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07692-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07692-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07692-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T19:02:34Z","timestamp":1746558154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07692-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7692"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07692-z","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"18 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All protocols in this study were approved by the Committee on the Ethics of Animal Experiments of Zhenghzou University, and all methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The patient provided written informed consent to the use and publication of his case for research and education purposes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"366"}}